Treatment of menstrual cycle-induced symptoms

IL290880BActive Publication Date: 2026-07-01PERIOD PILL BV
0 Cites 0 Cited by

Patent Information

Application Number
IL290880
Authority / Receiving Office
IL · IL
Patent Type
Patents
Current Assignee / Owner
Priority Date
2019-08-26
Filing Date
2020-08-26
Publication Date
2026-07-01
Estimated Expiration
2040-08-26

AI Technical Summary

Technical Problem

Current treatments for menstrual cycle-induced symptoms, such as PMS and PMDD, are often costly and have significant side effects, and existing pharmacological solutions are not ideal for addressing the full spectrum of physical and behavioral symptoms effectively.

Method used

The use of 3-methylmethcathinone (3-MMC) is proposed for treating menstrual cycle-induced symptoms, administered in specific dosages and timing relative to the menstrual cycle to alleviate both somatic and mood-related symptoms, with a kit including the drug and instructions for administration.

Benefits of technology

3-MMC provides effective relief for a range of menstrual cycle-induced symptoms with minimal side effects, improving quality of life by reducing symptom severity and duration, and can be administered before, during, or after symptoms occur, offering a more effective alternative to conventional treatments.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The present invention relates to methods of treatment of menstrual cycle induced disorders and symptoms with cathinone, particularly methods employing 3-methyl methcathinone (3-MMC). The present invention also relates to kits comprising 3-MMC for use in the treatment of subjects suffering from menstrual cycle induced disorders and symptoms. In particular, methods and kits for therapy of menstrual cycle induced disorders and symptoms with 3-MMC for a variety of disorders and / or conditions, including PMS, PMDD and perimenstrual disorders are provided.
Need to check novelty before this filing date? Find Prior Art